US Stock MarketDetailed Quotes

VVOS Vivos Therapeutics

Watchlist
  • 2.3600
  • +0.1400+6.31%
Close Jul 1 16:00 ET
  • 2.3900
  • +0.0300+1.27%
Post 19:39 ET
8.02MMarket Cap-213P/E (TTM)

Vivos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
28.91%-2.52M
39.01%-11.95M
8.40%-2.75M
52.07%-2.8M
38.69%-2.86M
41.81%-3.54M
-24.48%-19.59M
27.22%-3M
-43.96%-5.84M
-26.23%-4.66M
Net income from continuing operations
-120.96%-3.76M
43.04%-13.58M
30.05%-4.26M
61.48%-2.09M
20.93%-5.53M
68.05%-1.7M
-17.53%-23.85M
17.64%-6.09M
0.35%-5.43M
-72.92%-6.99M
Operating gains losses
100.24%6K
-487.07%-3.04M
-16.22%217K
-1,858.00%-1.76M
532.53%1.05M
-144.49%-2.55M
-323.28%-518K
--259K
--100K
--166K
Depreciation and amortization
-16.57%146K
-7.17%621K
-11.83%149K
-15.34%149K
-47.70%148K
326.83%175K
-8.73%669K
0.60%169K
-8.81%176K
45.13%283K
Other non cash items
----
--87K
----
----
----
----
----
----
----
----
Change In working capital
244.21%802K
67.39%2.86M
-51.96%906K
168.96%713K
-16.84%1.01M
165.08%233K
6,010.71%1.71M
8.64%1.89M
-1,144.44%-1.03M
349.39%1.22M
-Change in receivables
-338.24%-324K
-65.82%255K
-93.64%26K
233.78%99K
-102.86%-6K
-32.34%136K
227.19%746K
-84.45%409K
80.11%-74K
111.69%210K
-Change in prepaid assets
-19.89%145K
729.09%912K
-77.25%152K
646.43%306K
56.00%273K
126.74%181K
111.59%110K
2,374.07%668K
-163.64%-56K
123.40%175K
-Change in payables and accrued expense
333.93%486K
356.89%1.16M
111.91%996K
118.25%209K
-5.92%-161K
-70.29%112K
-135.83%-450K
-12.96%470K
-243.13%-1.15M
-125.46%-152K
-Change in other current liabilities
83.93%-9K
662.91%1.15M
30.77%-81K
89.47%108K
413.48%1.18M
-194.74%-56K
--151K
40.31%-117K
2,750.00%57K
--230K
-Change in other working capital
460.00%504K
-152.95%-611K
-141.01%-187K
-104.89%-9K
-136.47%-275K
41.67%-140K
327.61%1.15M
136.05%456K
143.91%184K
-40.40%754K
Cash from discontinued investing activities
Operating cash flow
28.91%-2.52M
39.01%-11.95M
8.40%-2.75M
52.07%-2.8M
38.69%-2.86M
41.81%-3.54M
-24.48%-19.59M
27.22%-3M
-43.96%-5.84M
-26.23%-4.66M
Investing cash flow
Cash flow from continuing investing activities
47.75%-151K
7.68%-853K
17.50%-165K
-54.00%-154K
51.39%-245K
-140.83%-289K
64.57%-924K
47.64%-200K
76.85%-100K
67.10%-504K
Net PPE purchase and sale
36.82%-151K
13.10%-803K
17.50%-165K
-54.00%-154K
51.39%-245K
-99.17%-239K
61.44%-924K
47.64%-200K
77.32%-100K
61.56%-504K
Net other investing changes
----
---50K
--0
--0
--0
---50K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
47.75%-151K
7.68%-853K
17.50%-165K
-54.00%-154K
51.39%-245K
-140.83%-289K
64.57%-924K
47.64%-200K
76.85%-100K
67.10%-504K
Financing cash flow
Cash flow from continuing financing activities
-50.58%3.64M
10.92M
3.57M
0
0
7.36M
0
0
0
0
Net common stock issuance
----
--12M
--4M
--0
----
----
--0
--0
--0
--0
Proceeds from stock option exercised by employees
-50.74%3.94M
----
----
----
----
--8M
----
----
----
----
Net other financing activities
52.56%-306K
---1.08M
---432K
--0
--0
---645K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-50.58%3.64M
--10.92M
--3.57M
--0
--0
--7.36M
--0
--0
--0
--0
Net cash flow
Beginning cash position
-53.31%1.64M
-85.36%3.52M
-85.30%988K
-68.87%3.94M
-60.48%7.05M
-85.36%3.52M
31.99%24.03M
-76.45%6.72M
-62.98%12.66M
26.82%17.83M
Current changes in cash
-72.55%968K
90.85%-1.88M
120.47%655K
50.29%-2.95M
39.93%-3.1M
156.87%3.53M
-452.18%-20.51M
28.95%-3.2M
-4.91%-5.94M
-125.66%-5.17M
End cash Position
-62.94%2.61M
-53.31%1.64M
-53.31%1.64M
-85.30%988K
-68.87%3.94M
-60.48%7.05M
-85.36%3.52M
-85.36%3.52M
-76.45%6.72M
-62.98%12.66M
Free cash flow
29.41%-2.67M
37.84%-12.75M
8.97%-2.91M
50.29%-2.95M
39.93%-3.1M
39.08%-3.78M
-13.13%-20.51M
28.95%-3.2M
-32.07%-5.94M
-3.24%-5.17M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 28.91%-2.52M39.01%-11.95M8.40%-2.75M52.07%-2.8M38.69%-2.86M41.81%-3.54M-24.48%-19.59M27.22%-3M-43.96%-5.84M-26.23%-4.66M
Net income from continuing operations -120.96%-3.76M43.04%-13.58M30.05%-4.26M61.48%-2.09M20.93%-5.53M68.05%-1.7M-17.53%-23.85M17.64%-6.09M0.35%-5.43M-72.92%-6.99M
Operating gains losses 100.24%6K-487.07%-3.04M-16.22%217K-1,858.00%-1.76M532.53%1.05M-144.49%-2.55M-323.28%-518K--259K--100K--166K
Depreciation and amortization -16.57%146K-7.17%621K-11.83%149K-15.34%149K-47.70%148K326.83%175K-8.73%669K0.60%169K-8.81%176K45.13%283K
Other non cash items ------87K--------------------------------
Change In working capital 244.21%802K67.39%2.86M-51.96%906K168.96%713K-16.84%1.01M165.08%233K6,010.71%1.71M8.64%1.89M-1,144.44%-1.03M349.39%1.22M
-Change in receivables -338.24%-324K-65.82%255K-93.64%26K233.78%99K-102.86%-6K-32.34%136K227.19%746K-84.45%409K80.11%-74K111.69%210K
-Change in prepaid assets -19.89%145K729.09%912K-77.25%152K646.43%306K56.00%273K126.74%181K111.59%110K2,374.07%668K-163.64%-56K123.40%175K
-Change in payables and accrued expense 333.93%486K356.89%1.16M111.91%996K118.25%209K-5.92%-161K-70.29%112K-135.83%-450K-12.96%470K-243.13%-1.15M-125.46%-152K
-Change in other current liabilities 83.93%-9K662.91%1.15M30.77%-81K89.47%108K413.48%1.18M-194.74%-56K--151K40.31%-117K2,750.00%57K--230K
-Change in other working capital 460.00%504K-152.95%-611K-141.01%-187K-104.89%-9K-136.47%-275K41.67%-140K327.61%1.15M136.05%456K143.91%184K-40.40%754K
Cash from discontinued investing activities
Operating cash flow 28.91%-2.52M39.01%-11.95M8.40%-2.75M52.07%-2.8M38.69%-2.86M41.81%-3.54M-24.48%-19.59M27.22%-3M-43.96%-5.84M-26.23%-4.66M
Investing cash flow
Cash flow from continuing investing activities 47.75%-151K7.68%-853K17.50%-165K-54.00%-154K51.39%-245K-140.83%-289K64.57%-924K47.64%-200K76.85%-100K67.10%-504K
Net PPE purchase and sale 36.82%-151K13.10%-803K17.50%-165K-54.00%-154K51.39%-245K-99.17%-239K61.44%-924K47.64%-200K77.32%-100K61.56%-504K
Net other investing changes -------50K--0--0--0---50K----------------
Cash from discontinued investing activities
Investing cash flow 47.75%-151K7.68%-853K17.50%-165K-54.00%-154K51.39%-245K-140.83%-289K64.57%-924K47.64%-200K76.85%-100K67.10%-504K
Financing cash flow
Cash flow from continuing financing activities -50.58%3.64M10.92M3.57M007.36M0000
Net common stock issuance ------12M--4M--0----------0--0--0--0
Proceeds from stock option exercised by employees -50.74%3.94M------------------8M----------------
Net other financing activities 52.56%-306K---1.08M---432K--0--0---645K----------------
Cash from discontinued financing activities
Financing cash flow -50.58%3.64M--10.92M--3.57M--0--0--7.36M--0--0--0--0
Net cash flow
Beginning cash position -53.31%1.64M-85.36%3.52M-85.30%988K-68.87%3.94M-60.48%7.05M-85.36%3.52M31.99%24.03M-76.45%6.72M-62.98%12.66M26.82%17.83M
Current changes in cash -72.55%968K90.85%-1.88M120.47%655K50.29%-2.95M39.93%-3.1M156.87%3.53M-452.18%-20.51M28.95%-3.2M-4.91%-5.94M-125.66%-5.17M
End cash Position -62.94%2.61M-53.31%1.64M-53.31%1.64M-85.30%988K-68.87%3.94M-60.48%7.05M-85.36%3.52M-85.36%3.52M-76.45%6.72M-62.98%12.66M
Free cash flow 29.41%-2.67M37.84%-12.75M8.97%-2.91M50.29%-2.95M39.93%-3.1M39.08%-3.78M-13.13%-20.51M28.95%-3.2M-32.07%-5.94M-3.24%-5.17M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg